As revolutionary drugs melt pounds, patients face a new aesthetic border of excessive skin and unexpected transformations
2025 is here and is the time for New Year’s resolutions when many set new weight loss goals. But what if this year’s resolutions were not just the will? As of January 1, 2025, Mounjaro and Wegovy will be subsidized in Israel, uniting the global impulse of GLP-1 receptor as transformative tools for weight loss and metabolic health.
For eligible patients, Mounjaro will be covered 50% of MacCabi and Meuhedet’s supplementary insurance plans, while Wegovy will be covered 50% of MacCabi and Clalit’s additional insurance plans. These drugs – including VICTOZA, SAXENDA and OZEMPIC – redefine approximation of obesity and type II diabetes, offering significant, prolonged weight loss.
While the benefits for the health of these drugs are widely celebrated, their deep effects on body composition and proportions also reshape the aesthetic landscape, with heavy thoughts. Patients who examine weight loss injections should be aware of the possible need for plastic surgery as part of the journey of weight loss, as dramatic weight reductions often leave excessive skin behind them and changes in facial appearance. This caused an increase in demand for body rejuvenation processes and facial rejuvenation.
The “Ozempic Face”
The term “ozempic face” has entered the aesthetic dictionary to describe the loss of tumor and skin looseness that many patients experience after rapid weight loss. Facelift processes, along with fat transplantation and skin fillers, are increasingly seeking to restore a youthful, balanced appearance. These techniques help to rejuvenate the hollow areas, in smooth fine lines and tighten the skin, complementing the transformation of the person starting with weight loss.
Excess skin after significant weight loss can affect additional areas, including abdomen, weapons, thighs, breasts and buttocks. Body contour procedures, such as abdominal (abdomen), armoplasty (arm lift), zero (lift), breast lifts and buttocks lifts have become decisive to help patients achieve analogy, harmoniously.
For optimal results, candidates are encouraged to wait until their weight is stabilized to ensure that the results remain durable and minimize the risks associated with further weight fluctuations.
GLP-1 receptor agonists lead to progressive weight loss, usually culminating in a 12-month mark. “For patients who examine plastic surgery due to excessive weight loss, this orbit informs the optimal period of procedures,” says Dr. Rod Rohrich, a previous president of American society of plastic surgeons and publisher-attorneys of “Plastic and Plastic”.
Balanced diet and exercise
For patients who think of plastic surgery after weight loss caused by GLP-1, time is critical. Surgery was performed very early – before the weight stabilized – it can lead to underlying results or the need for revisions. Similarly, maintaining weight loss after surgery is critical for maintaining aesthetic effects. With questions about the potential to increase recovery weight after stopping GLP-1 treatment, patients are recommended to adopt sustainable lifestyle changes, including a balanced diet and exercise to support their long-term goals.
As we look ahead, in 2025 it marks a new era of weight loss solutions, offering patients the opportunity to redefine their metabolic health and aesthetic goals as never before. This transformative journey requires strategic planning to achieve continuous results and maximize the benefits of GLP-1 receptor fighters.
Dr. Stav Brown is a physician-scientist, Forbes 30 under 30 graduates, and contributing to Forbes Israel, which covers health, medicine, science and innovation.
Forbes Israel’s contributors are independent writers selected by the editorial team forbes, experts in their field, providing professional comments and reviews in their field of expertise. The content is not durable, reflects its personal views and is solely responsible.
The information provided is only for educational and information purposes and should not be interpreted as medical advice. People looking for personal medical guidance should be consulted with an authorized health care professional.
